GlassScriptPhysician profile
Rachael L Seets
NPI 1356608491
$1,116.06
in general payments reported to CMS, 2019-2025
12 companies · $243 in 2025
The $243 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $873 · 2025: $243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $439.93 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $291.72 | 2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $147.33 | 2025 | Uptravi, Opsumit |
| Amgen INC. | $51.10 | 2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $36.50 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $33.75 | 2024 | |
| Janssen Pharmaceuticals, INC | $33.74 | 2024 | Xarelto |
| Abbott Laboratories | $19.62 | 2024 | Mitraclip |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.67 | 2024 | Jardiance |
| Merck Sharp & Dohme LLC | $16.78 | 2024 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $15.39 | 2024 | Brilinta |
| Elutia, INC. | $11.53 | 2024 | Ecm Patch,Pouch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachael Seets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.